Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lung cancer vaccine (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Oct 2017 Biomarkers information updated
- 19 Feb 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 04 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.